Article
Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
2022-01-23
Abstract excerpt
<h4>Background</h4> Although high vaccine effectiveness of messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines was reported in studies in several countries, data is limited from Asian countries, especially against the Delta (B.1.617.2) variant. <h4>Methods</h4> We conducted a multicenter test-negative case-control study in patients aged ≥16 visiting hospitals or clinics with signs or symptoms consist...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 53f4578d-7242-5139-b22d-fc1178c5addd
- DOI
- 10.1101/2022.01.17.22269394
